PL2721009T3 - Pochodne pirazolu użyteczne jako inhibitory syntazy aldosteronu - Google Patents

Pochodne pirazolu użyteczne jako inhibitory syntazy aldosteronu

Info

Publication number
PL2721009T3
PL2721009T3 PL12727984T PL12727984T PL2721009T3 PL 2721009 T3 PL2721009 T3 PL 2721009T3 PL 12727984 T PL12727984 T PL 12727984T PL 12727984 T PL12727984 T PL 12727984T PL 2721009 T3 PL2721009 T3 PL 2721009T3
Authority
PL
Poland
Prior art keywords
synthase inhibitors
pyrazole derivatives
derivatives useful
aldosterone synthase
aldosterone
Prior art date
Application number
PL12727984T
Other languages
English (en)
Inventor
Michael Gregory Bell
Paul J Hoogestraat
Thomas Edward Mabry
Quanrong Shen
Ana Maria Escribano
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2721009(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL2721009T3 publication Critical patent/PL2721009T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL12727984T 2011-06-14 2012-06-07 Pochodne pirazolu użyteczne jako inhibitory syntazy aldosteronu PL2721009T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11
EP12727984.2A EP2721009B1 (en) 2011-06-14 2012-06-07 Pyrazole derivatives useful as aldosterone synthase inhibitors
PCT/US2012/041212 WO2012173849A1 (en) 2011-06-14 2012-06-07 Pyrazole derivatives useful as aldosterone synthase inhibitors

Publications (1)

Publication Number Publication Date
PL2721009T3 true PL2721009T3 (pl) 2016-01-29

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12727984T PL2721009T3 (pl) 2011-06-14 2012-06-07 Pochodne pirazolu użyteczne jako inhibitory syntazy aldosteronu

Country Status (33)

Country Link
US (1) US8778984B2 (pl)
EP (1) EP2721009B1 (pl)
JP (1) JP5890012B2 (pl)
KR (1) KR101555119B1 (pl)
CN (1) CN103596930B (pl)
AR (1) AR086665A1 (pl)
AU (1) AU2012271023A1 (pl)
BR (1) BR112013031873A2 (pl)
CA (1) CA2836804C (pl)
CL (1) CL2013003536A1 (pl)
CO (1) CO6821955A2 (pl)
CR (1) CR20130601A (pl)
CY (1) CY1116687T1 (pl)
DK (1) DK2721009T3 (pl)
DO (1) DOP2013000284A (pl)
EA (1) EA201391655A1 (pl)
EC (1) ECSP13013080A (pl)
ES (1) ES2548210T3 (pl)
GT (1) GT201300307A (pl)
HK (1) HK1193103A1 (pl)
HR (1) HRP20150939T1 (pl)
HU (1) HUE026461T2 (pl)
IL (1) IL229485A0 (pl)
ME (1) ME02223B (pl)
MX (1) MX336042B (pl)
PE (1) PE20140606A1 (pl)
PL (1) PL2721009T3 (pl)
PT (1) PT2721009E (pl)
RS (1) RS54269B1 (pl)
SG (1) SG194822A1 (pl)
SI (1) SI2721009T1 (pl)
TW (1) TWI518073B (pl)
WO (1) WO2012173849A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170253577A1 (en) * 2014-07-04 2017-09-07 Japan Tobacco Inc. Method for producing indole compound
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
WO2007111175A1 (ja) 2006-03-17 2007-10-04 Ngk Insulators, Ltd. 目封止ハニカム構造体の製造方法
ES2472446T3 (es) 2009-11-30 2014-07-01 Novartis Ag Derivados de imidazol como inhibidores de aldosterona sintasa
SI2523731T1 (sl) 2010-01-14 2019-02-28 Novartis Ag Uporaba sredstva, ki modificira adrenalni hormon

Also Published As

Publication number Publication date
CA2836804A1 (en) 2012-12-20
US20120322841A1 (en) 2012-12-20
CN103596930B (zh) 2015-05-13
AU2012271023A1 (en) 2013-11-28
ECSP13013080A (es) 2014-01-31
CO6821955A2 (es) 2013-12-31
BR112013031873A2 (pt) 2016-12-13
EP2721009B1 (en) 2015-08-12
KR20140009564A (ko) 2014-01-22
JP2014517034A (ja) 2014-07-17
HK1193103A1 (en) 2014-09-12
EP2721009A1 (en) 2014-04-23
CY1116687T1 (el) 2017-03-15
CL2013003536A1 (es) 2014-07-11
ES2548210T3 (es) 2015-10-14
DOP2013000284A (es) 2014-06-30
AR086665A1 (es) 2014-01-15
HRP20150939T1 (en) 2015-10-09
SI2721009T1 (sl) 2015-10-30
WO2012173849A1 (en) 2012-12-20
CA2836804C (en) 2016-05-24
US8778984B2 (en) 2014-07-15
CN103596930A (zh) 2014-02-19
MX336042B (es) 2016-01-07
ME02223B (me) 2016-02-20
RS54269B1 (en) 2016-02-29
CR20130601A (es) 2014-05-02
SG194822A1 (en) 2013-12-30
EA201391655A1 (ru) 2014-07-30
PE20140606A1 (es) 2014-05-17
DK2721009T3 (en) 2015-10-26
MX2013014790A (es) 2014-01-24
NZ617642A (en) 2015-11-27
KR101555119B1 (ko) 2015-09-22
JP5890012B2 (ja) 2016-03-22
IL229485A0 (en) 2014-01-30
GT201300307A (es) 2014-11-24
TWI518073B (zh) 2016-01-21
HUE026461T2 (en) 2016-05-30
PT2721009E (pt) 2015-10-23
TW201311647A (zh) 2013-03-16

Similar Documents

Publication Publication Date Title
HK1223371A1 (zh) 用作 抑制劑的稠合咪唑衍生物
EP2757884A4 (en) PYRAZOLOPYRIDYL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER
ZA201204959B (en) Pyrazole derivatives as jak inhibitors
HK1195552A1 (en) Pyrrolotriazinone derivatives as pi3k inhibitors pi3k
ZA201305826B (en) Substituted amminobutyric derivatives as neprilysin inhibitors
EP2552208A4 (en) IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
EP2615916A4 (en) CONDENSED PYRAZOLE DERIVATIVES AS NEW ERK INHIBITORS
EP2552214A4 (en) PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
IL228103A0 (en) Amino-quinolines as kinase inhibitors
EP2552211A4 (en) INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
EP2701512A4 (en) INHIBITORS OF ALDOSTERONE SYNTHASE
HK1191862A1 (zh) 吡唑衍生物
EP2685992A4 (en) AMINO-QUINOLINES AS KINASE INHIBITORS
EP2757882A4 (en) IMIDAZOPYRIDYL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER
EP2861071A4 (en) ALDOSTERONSYNTHASEHEMMER
EP2757883A4 (en) TRIAZOLOPYRIDYL COMPOUNDS FOR USE AS INHIBITORS OF ALDOSTERONE SYNTHASE
HRP20150939T1 (en) Pyrazole derivatives useful as aldosterone synthase inhibitors
EP2934144A4 (en) INDAZOL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER